Medically reviewed by Nicholas R. Metrus, MD Tardive dyskinesia and dystonia are both neurological disorders that can affect ...

Tardive dyskinesia can progress to interfere with almost all activities of daily living like getting dressed, eating, and drinking, added Rose. "In some cases, it can require a feeding tube." ...

Novel once-weekly injectable VMAT2 inhibitor targets underserved patients with serious adherence and access challenges – - Potential expansion into Huntington’s chorea – an underserved indication with ...

Dyskinesia Pipeline constitutes 40+ key companies continuously working towards developing 45+ Dyskinesia treatment therapies, analyzes DelveInsightNew York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE ...

Neurology > General Neurology Year in Review: Tardive Dyskinesia — New VMAT2 formulations, case reports, screening tools, and long-term data in 2024 by Kristen Monaco, Senior Staff Writer ...

I was self-conscious about having tardive dyskinesia symptoms in my first job after my last hospitalization. However, I got ...

Amantadine extended-release (ER) capsules reduce levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD), a phase 3 placebo-controlled trial has shown. "Our study showed that ...

Tardive dyskinesia can occur as a side effect of certain drugs that treat mental health conditions and can take a deeper toll on your well-being. Get tips to cope.

Tardive dyskinesia predominantly occurs in response to the cessation of dopamine receptor antagonists/ dopamine receptor blockers agents (DRBAs) or partial agonists, including first-generation and ...

Although tardive dyskinesia only affects up to 25 percent of people taking these prescription drugs, according to a review published in October 2021 in the journal Neuropsychiatric Disease and ...

In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), expression of the dopamine D3 receptor was decreased. However, levodopa-induced dyskinesia (LID), similar ...